Cypress Asset Management’s ResMed RMD Stock Holding History

Cypress Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,200	Closed	-$238K	–	109
2024 Q1	$238K	Sell	1,200 -25	-2%	-$4.58K	0.06%	104
2023 Q4	$211K	Buy	+1,225	New	+$188K	0.06%	112
2023 Q3	–	Sell	-1,325	Closed	-$290K	–	121
2023 Q2	$290K	Hold	1,325	–	–	0.09%	110
2023 Q1	$290K	Hold	1,325	–	–	0.1%	111
2022 Q4	$276K	Hold	1,325	–	–	0.1%	113
2022 Q3	$289K	Hold	1,325	–	–	0.11%	109
2022 Q2	$278K	Hold	1,325	–	–	0.1%	110
2022 Q1	$321K	Hold	1,325	–	–	0.09%	116
2021 Q4	$345K	Hold	1,325	–	–	0.08%	118
2021 Q3	$349K	Hold	1,325	–	–	0.09%	117
2021 Q2	$327K	Hold	1,325	–	–	0.08%	119
2021 Q1	$257K	Hold	1,325	–	–	0.07%	127
2020 Q4	$282K	Hold	1,325	–	–	0.08%	130
2020 Q3	$227K	Hold	1,325	–	–	0.07%	128
2020 Q2	$254K	Buy	+1,325	New	+$217K	0.08%	119
2020 Q1	–	Sell	-1,325	Closed	-$205K	–	131
2019 Q4	$205K	Buy	+1,325	New	+$191K	0.07%	129
2019 Q2	–	Sell	-2,560	Closed	-$266K	–	146
2019 Q1	$266K	Sell	2,560 -400	-14%	-$41.3K	0.09%	135
2018 Q4	$337K	Buy	+2,960	New	+$317K	0.13%	123

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cypress Asset Management's RMD Position: Q2 2024 in Review

Cypress Asset Management sold out of ResMed (RMD) in Q2 2024, closing a stake of 1,200 shares — an estimated $238K sold.

Cypress Asset Management first reported a position in RMD in Q4 2018 and held it in 18 quarters. The position peaked at $349K in Q3 2021. 771 funds tracked by Wall St. Rank hold RMD as of Q2 2024.

Cypress Asset Management reported no remaining ResMed position as of Q2 2024 after selling out during the quarter.
Cypress Asset Management sold 1,200 ResMed shares in Q2 2024, an estimated $238K.
Cypress Asset Management first reported a position in ResMed in Q4 2018 and held it in 18 quarters.
Cypress Asset Management's ResMed position peaked at $349K in Q3 2021.
771 funds tracked by Wall St. Rank held ResMed as of Q2 2024.

Based on Cypress Asset Management's 13F filing for Q2 2024, filed 24 Feb 2025.